improving the diagnosis of bladder cancer in the bladderpath study
Published 1 year ago • 72 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
3:12
bladderpath: reducing bladder treatment times with mri scans
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
1:21
how can we improve responses to immunotherapy in patients with bladder cancer?
-
4:00
2022 who classification: updates in bladder cancer
-
5:06
state of the art research in bladder cancer treatment
-
1:08
the role of molecular biomarkers in determining patient response to bladder cancer treatment
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
3:35
genomic subtyping in bladder cancer
-
4:24
retain bladder: a risk-adapted approach to muscle invasive bladder cancer
-
1:00
photodynamic surgery as a diagnostic and therapeutic approach for bladder cancer
-
0:49
how can ai and machine learning influence treatment decisions in bladder cancer?
-
1:11
maintenance therapy for bladder cancer
-
4:19
novel biomarkers for outcomes identified in bcg-treated t1hg bladder cancer
-
2:29
bladder cancer treatment updates by prof. jones
-
0:37
bladder-sparing approaches in muscle-invasive urothelial carcinoma
-
1:39
the role of urinary comprehensive genomic profiling in managing bladder cancer
-
1:54
highlights in bladder cancer at esmo 2022
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer